Home / Intelligence

Type
  • All
  • Blog
  • Briefs
  • Case Studies
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Featured Topic
  • All
  • AIML
  • Analytics
  • APAC
  • Benchmarking
  • Biosimilars
  • CAR-T
  • Cell and Gene Therapy
  • Commercial Operations
  • Competitive Intelligence
  • Contract Analytics
  • Corporate Strategy
  • COVID-19
  • Customer Engagement
  • Data Management
  • Digital Therapeutics
  • Diversity
  • Emerging Life Sciences
  • Europe
  • Evidence Strategy (HEOR)
  • Field Force
  • Forecasting
  • Generative AI
  • Incentive Compensation
  • Inflation Reduction Act
  • Insights
  • International
  • LatAm
  • Launch and Brand Excellence
  • Learning and Development
  • Market Research
  • Marketing
  • Medical Affairs
  • MedTech
  • New Product Planning
  • NRDL
  • Omnichannel
  • Oncology
  • Patient Centricity
  • Patient Finding
  • Patient Services
  • Performance Tracking
  • Pricing and Access
  • Product Demos
  • Rare Disease
  • Real-World Evidence
  • Scientific Publications
  • Sustainability
  • Talent Acquisition and Retention
  • United States
  • Value Communication
Search
Interconnected earth

Blog

5 Key Trends in Global Market Access

Key impacts on the market access and payer environment are beginning to unfold from policies enacted in 2023 and new policies enacting in 2024. To gather insights into the latest trends, Trinity Life Sciences conducted interviews with key stakeholders across various pricing and market access landscapes. Trinity is closely monitoring the evolving global advanced therapeutics market environment to determine implications for payers and manufacturers and help them prepare for the year ahead.

Read Now

Webinars

Brand Health 2022: A Strategic, Data-Driven Approach to Brand Assessment

Available On Demand

December 1st, 2021 | 1:00 pm EST In today’s highly competitive market, innovation and creativity are critical to create a strong Brand Strategy that supports meaningful differentiation.  A key challenge for life sciences companies in 2022 will be to identify the clearest strategies to address brand performance and assessing brand health for their unique context. Whether your brand is on-market already or is preparing for launch, leveraging a nuanced, evidence-based view of performance drivers – from prescriber adoption, to payer…

Watch Now

Blog

AI-Based Software Paige Prostate is Granted FDA Approval Through the De Novo Regulatory Pathway

Published September 27, 2021

Paige Prostate is the first artificial intelligence (AI)-based software designed to identify areas of concern (i.e., high likelihood of containing cancer) on a prostate biopsy image so they can be flagged for further review by a pathologist. The program is intended to be used as an adjunct tool to the review of digital scanner slide images from prostate biopsies. The program was reviewed through the De Novo pathway, a regulatory pathway for low-to-moderate risk novel devices. The FDA authorization is based…

Read Now

Blog

Part II: Non-Traditional Players Attempting Entry into the Healthcare Sector

Published September 22, 2021

Executive Summary In June 2021, Walmart announced it is partnering with Novo Nordisk to produce its own private label insulin, ReliOn, at a discount to Novo Nordisk’s currently available fast-acting insulin Through this partnership, Americans with a high-deductible health plan (HDHP) or without insurance can save up to 75% and purchase the insulin at their local Walmart Novo Nordisk’s key competitors, Eli Lilly and Sanofi are likely to respond with a similar partnership or price-cut for their insulin to remain…

Read Now

Webinars

Everything You Wanted to Know About Patient Finding but Were Afraid to Ask

Available On Demand

According to a TGaS Advisors’ large landscape study, 45% of all machine learning commercial use cases in the life sciences industry were for finding patients, often for HCP alerts and targeting. In fact, if you are not doing patient finding alerts/targeting, you are probably behind the industry.Come join TGaS Advisors, a division of Trinity Life Sciences, as we share the “ins and outs” of patient finding, including learnings from our study. It’s clear that patient finding can have a big…

Watch Now

Blog

Part I: Non-Traditional Players Attempting Entry Into the Healthcare Sector

Published September 8, 2021

Executive Summary The healthcare sector is becoming increasingly attractive, and despite the risk of an expensive failed venture, non-traditional players have and will likely continue to take their chances to enter the field While the market has been profitable for some players such as Fujifilm and Nestlé, others have had a challenging time competing in this uniquely complex market (e.g., Kodak and Heaven) Trinity’s take: Non-traditional players that have been successful in tapping into the healthcare sector seem to follow a…

Read Now

Blog

Exploring the Impact of COVID-Driven Trends on the US Healthcare Landscape

Published September 1, 2021

Executive Summary The COVID-19 pandemic has called into question many elements of the US healthcare system across key stakeholders, resulting in changes across patients, providers, payers, researchers, and manufacturers The pandemic has required many healthcare providers and patients to provide telemedicine options, which for many specialties has proved to be an effective way to dispense and receive care For payers at the national level, CMS has implemented reimbursable telehealth codes for all medical services that may be provided remotely, while…

Read Now

Blog

Verily to Acquire SignalPath, Expanding the Company’s Clinical Research Capabilities

Published August 30, 2021

Verily recently announced its first major acquisition, a software platform known as SignalPath. SignalPath’s flagship software, TrialPath, digitizes and modulates individual protocols in a clinical trial, from budgeting to tracking point-of-care communication. The acquisition would fold SignalPath into Baseline, Verily’s clinical research platform designed to improve clinical trial execution, help research manage their clinical trials, and explore flexible study options for decentralized and hybrids trials as well as novel ways to capture real-world data (i.e., generated by novel sensors and biomarkers). While…

Read Now

Case Studies

Global Value Messaging and P&MA Strategy for a CAR-T Cell Therapy

Trinity completed an engagement to support the successful launch of a CAR-T cell therapy with distinct clinical profile in a competitive landscape. Geographic Scope: Client Situation The client asked Trinity to develop and externally validate global payer value messages and the associated evidence set for their CAR T cell therapy. They also required support with developing a robust global pricing and market access strategy for their asset. Trinity’s Solution Trinity conducted focus groups and In-Depth-Interviews (IDIs) with key payer and provider stakeholders in scope markets to understand…

Read Now

Case Studies

Assessment of the Impact of National Guidelines on Uptake of a Biomarker Among HCPs and Payers

Trinity designed staggered quantitative research to assess the impact of national guidelines on uptake of a biomarker among HCPs and payers. Geographic Scope: Client Situation The client wanted to understand the impact of national physician society guidelines on uptake / acceptance of an innovative biomarker based on developed patient vignettes, and expectations for updates to payer diagnostic testing polices. Trinity’s Solution Trinity conducted qualitative research, fielding a survey with physicians and payers, to determine current physician utilization and payer coverage of biomarker diagnostic test and track evolution in payer policies and…

Read Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.